Fueled by evolving healthcare demands, the pharmaceutical industry is undergoing a metamorphosis, harnessing cutting-edge technologies to redefine the drug discovery and development process.
Recent market analyses paint a compelling picture of the global drug discovery market, valued at USD 81.5 billion in 2022 and poised to reach an impressive USD 181.4 billion by 2032, showcasing a remarkable CAGR of 8.5 percent from 2023 to 2032. The principal factors driving this market growth are escalating R&D activities, the integration of artificial intelligence, virtual clinical trials, digital health technologies, and the rise of personalized medicine. These trends signal a shift toward a more efficient, patient-centric drug development sector, streamlining operations, enhancing health outcomes, and fortifying companies to confront future healthcare challenges.
This edition of Pharma Tech Outlook APAC brings forth the most influential developments in the drug discovery and development landscape, offering insights from thought leaders who are sculpting the future of healthcare. The edition features Ulf Andersson, the head of preclinical safety and translational pharmacology at Debiopharm, who emphasizes the pivotal role of AI in toxicology testing, underscoring the necessity for parallel development in multi-organ and multi-micro physiological systems to achieve unparalleled efficiency and accuracy. It also brings to light valuable observations from Suci Ameliya Reza Zairizal, associate manager at Novugen, who advocates for creativity in communication strategies for generic drug makers, urging a shift in focus toward unique product capabilities and qualities, steering away from extensive marketing promotions.
Along with these vital insights from industry experts, the edition features SXULTRASONIC, a global center of research and technology, which champions a holistic approach to advancing healthcare solutions through collaborative in-house research and development that transcends conventional boundaries.
In this edition featuring the Top Drug Discovery and Development Solutions Providers in APAC for 2023, we hope you find the appropriate company best suited to meet your business requirements.
Let us know your thoughts!
